Evidence map›Paper›PMID 19063828›Full record

ReviewCurrent allergy and asthma reports2009

Fixed drug eruption: a prototypic disorder mediated by effector memory T cells.

Yoshiko Mizukawa, Tetsuo Shiohara

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current allergy and asthma reports, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Etoricoxib-Induced Fixed Erythema.Journal of clinical medicine · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Fixed drug eruption-induced balanoposthitis: a case report.International journal of impotence research · 2024
    Article
  7. Severe cutaneous adverse reactions.Nature reviews. Disease primers · 2024
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Drug desensitization in allergic children.Acta bio-medica : Atenei Parmensis · 2019
    Review
  15. Article
  16. Article
  17. Drug allergy: causes and desensitization.Human vaccines & immunotherapeutics · 2012
    Review
  18. Mucosal fixed drug eruption in a patient treated with ornidazole.Journal of dermatological case reports · 2012
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yoshiko MizukawaDepartment of Dermatology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan. ymizu@ks.kyorin-u.ac.jp
Tetsuo Shiohara
Kyorin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effector memory T cells are uniquely specialized to mediate protective immunity. However, their excessive activation may result in the development of organ-specific inflammatory diseases, which have not been extensively studied. Fixed drug eruption (FDE), a localized variant of drug-induced dermatoses characterized by relapse in the same location, is a prototypic disorder mediated by excessive activation of effector memory T cells, which are resident in the lesional epidermis. A variety of clinical and pathologic features uniquely observed in FDE lesions can be explained by the presence of CD8(+) intraepidermal T cells with the effector memory phenotype in the FDE lesion. This review focuses on how these T cells are generated, retained in the epidermis, and activated to cause epidermal damage.

Indexed as

Immunologic MemoryCD8-Positive T-LymphocytesCytokinesDermatitisDrug EruptionsEpidermisHumansInterferon-gammaSkinT-Lymphocytes, RegulatoryCytokinesInterferon-gamma

Identifiers

PMID19063828
OpenAlexW2070977172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.